These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22942668)

  • 1. Improved deposition and deprotection of silane tethered 3,4 hydroxypyridinone (HOPO) ligands on functionalized nanoporous silica.
    Davidson JD; Wiacek RJ; Burton S; Li XS; Fryxell GE; Addleman RS; Yantasee W; Sangvanich T; Pattamakomsan K
    Inorg Chem Commun; 2012 Apr; 18():92-96. PubMed ID: 22942668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective capture of radionuclides (U, Pu, Th, Am and Co) using functional nanoporous sorbents.
    Yantasee W; Fryxell GE; Pattamakomsan K; Sangvanich T; Wiacek RJ; Busche B; Addleman RS; Timchalk C; Ngamcherdtrakul W; Siriwon N
    J Hazard Mater; 2019 Mar; 366():677-683. PubMed ID: 30580142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxypyridinone functionalized self-assembled monolayers on nanoporous silica for sequestering lanthanide cations.
    Yantasee W; Fryxell GE; Lin Y; Wu H; Raymond KN; Xu J
    J Nanosci Nanotechnol; 2005 Apr; 5(4):527-9. PubMed ID: 16004114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of 3-benzyloxy-2-pyridinone functional linkers: Tools for the synthesis of 3,2-hydroxypyridinone (HOPO) and HOPO/hydroxamic acid chelators.
    Gibson S; Fernando R; Jacobs HK; Gopalan AS
    Tetrahedron; 2015 Dec; 71(49):9271-9281. PubMed ID: 26640304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of hydroxypyridinone ligands into self-assembled monolayers on mesoporous supports for selective actinide sequestration.
    Lin Y; Fiskum SK; Yantasee W; Wu H; Mattigod SV; Vorpagel E; Fryxell GE; Raymond KN; Xu J
    Environ Sci Technol; 2005 Mar; 39(5):1332-7. PubMed ID: 15787374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective mitigation of gadolinium deposition using the bidentate hydroxypyridinone ligand Me-3,2-HOPO.
    Sun Q; Wang X; Shi C; Guan J; Chen L; Wang Y; Wang S; Diwu J
    Dalton Trans; 2022 Aug; 51(34):13055-13060. PubMed ID: 35971987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hexadentate terephthalamide(bis-hydroxypyridinone) ligands for uranyl chelation: structural and thermodynamic consequences of ligand variation.
    Szigethy G; Raymond KN
    J Am Chem Soc; 2011 May; 133(20):7942-56. PubMed ID: 21542587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chelating agents for uranium(VI): 2. Efficacy and toxicity of tetradentate catecholate and hydroxypyridinonate ligands in mice.
    Durbin PW; Kullgren B; Ebbe SN; Xu J; Raymond KN
    Health Phys; 2000 May; 78(5):511-21. PubMed ID: 10772024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gd-hydroxypyridinone (HOPO)-based high-relaxivity magnetic resonance imaging (MRI) contrast agents.
    Datta A; Raymond KN
    Acc Chem Res; 2009 Jul; 42(7):938-47. PubMed ID: 19505089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New agents for in vivo chelation of uranium(VI): efficacy and toxicity in mice of multidentate catecholate and hydroxypyridinonate ligands.
    Durbin PW; Kullgren B; Xu J; Raymond KN
    Health Phys; 1997 Jun; 72(6):865-79. PubMed ID: 9169929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Synthetic Approach for the Incorporation of 3,2-Hydroxypyridinone (HOPO) Ligands: Synthesis of Structurally Diverse Poly HOPO Chelators.
    Arumugam J; Brown HA; Jacobs HK; Gopalan AS
    Synthesis (Stuttg); 2011 Jan; 2011(1):57-64. PubMed ID: 21709749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and iron chelating properties of hydroxypyridinone and hydroxypyranone hexadentate ligands.
    Zhou T; Kong XL; Hider RC
    Dalton Trans; 2019 Mar; 48(10):3459-3466. PubMed ID: 30793715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,2-Hydroxypyridinone (3,2-HOPO) vinyl sulfonamide and acrylamide linkers: Aza-Michael addition reactions and the preparation of poly-HOPO chelators.
    Martinez G; Arumugam J; Jacobs HK; Gopalan AS
    Tetrahedron Lett; 2013 Feb; 54(7):630-634. PubMed ID: 23355751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiolytic Evaluation of 3,4,3-LI(1,2-HOPO) in Aqueous Solutions.
    Wang Y; Mezyk SP; McLachlan JR; Grimes TS; Zalupski PR; O'Bryan HMT; Cook AR; Abergel RJ; Horne GP
    J Phys Chem B; 2023 May; 127(17):3931-3938. PubMed ID: 37084416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Lanthanide Sensing with Gold Nanoparticles and Hydroxypyridinone Chelators.
    Pallares RM; Carter KP; Zeltmann SE; Tratnjek T; Minor AM; Abergel RJ
    Inorg Chem; 2020 Feb; 59(3):2030-2036. PubMed ID: 31971379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thorium(IV) complexes of bidentate hydroxypyridinonates.
    Xu J; Whisenhunt DW; Veeck AC; Uhlir LC; Raymond KN
    Inorg Chem; 2003 Apr; 42(8):2665-74. PubMed ID: 12691574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hexadentate hydroxypyridonate iron chelators based on TREN-Me-3,2-HOPO: variation of cap size.
    Xu J; O'Sullivan B; Raymond KN
    Inorg Chem; 2002 Dec; 41(25):6731-42. PubMed ID: 12470069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific sequestering agents for the actinides. 21. Synthesis and initial biological testing of octadentate mixed catecholate-hydroxypyridinonate ligands.
    Uhlir LC; Durbin PW; Jeung N; Raymond KN
    J Med Chem; 1993 Feb; 36(4):504-9. PubMed ID: 8386249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Removal of a gadolinium based contrast agent by a novel sorbent hemoperfusion in a chronic kidney disease (CKD) rodent model.
    Ngamcherdtrakul W; Morry J; Sangvanich T; Reda M; Bejan DS; Fryxell GE; Yantasee W
    Sci Rep; 2019 Jan; 9(1):709. PubMed ID: 30679698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxypyridinone Derivatives: A Low-pH Alternative to Polyaminocarboxylates for TALSPEAK-like Separation of Trivalent Actinides from Lanthanides.
    Wang Y; Deblonde GJ; Abergel RJ
    ACS Omega; 2020 Jun; 5(22):12996-13005. PubMed ID: 32548484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.